Skip to content

A Pilot Study of Topical Honey for the Treatment of Rosacea

In adult patients with rosacea is topical medical-grade honey acceptable and does it appear to reduce the severity of rosacea?

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12612000565842
Enrollment
10
Registered
2012-05-25
Start date
2012-07-11
Completion date
2012-10-31
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

There are reasons to believe that medical grade-honey applied directly to skin may be an effective treatment for rosacea. In this study 10 adults with rosacea will apply honey to their face for 30-60 minutes twice daily for 2 weeks. After two weeks the rosacea will be assessed to look at changes in severity. Participants will also be asked about their experience of using honey. This trial will provide useful information on the practicalities of topical honey as a treatment for rosacea. It will also give an initial signal as to whether honey may be effective.

Interventions

Topical medical grade honey applied to rosacea for 30-60 minutes twice daily for 2 weeks. The subject will apply a sufficient amount of honey to create a thin film over the affected area on their face.

Sponsors

Medical Research Institute of New Zealand
Lead SponsorCharities/Societies/Foundations

Study design

Allocation
Non-randomised trial
Primary purpose
Treatment

Eligibility

Sex/Gender
All
Age
16 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Aged 16 or over at the time of enrolment Roasacea involving the upper or lower limbs Bilateral lesions, to allow comparison

Exclusion criteria

Requirement for topical or systemic corticosteroids, as judged by treating doctor Requirement for antibiotic therapy, as judged by treating doctor Known or suspected allergy to honey Any other condition which, at the investigators discretion, it is believed may present a safety risk or impact the feasibility of the study or the study results

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026